C.M.L. Hermans - Wageningen University & Research

基本信息

浏览量：0

职业迁徙

个人简介

C.M.L. Hermans currently works at the Wageningen Environmental Research, Wageningen University & Research. C.M.L. does research in Animal Science and Environmental Science. Her current project is Plant Benefits for health and wellbeing.

研究兴趣

论文共 634 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Underevaluated Impacts of the Therapeutic Revolution of Hemophilia on Women and Girls

Cedric Hermans,Evelien Krumb,Dawn Rotellini,Glenn F. Pierce

JOURNAL OF THROMBOSIS AND HAEMOSTASISno. 4 (2024): 915-918

引用0浏览0WOS引用

Eptacog Beta for the Management of Patients with Haemophilia A and B with Inhibitors: A European Perspective

Wolfgang Miesbach,Manuel Carção, Johnny Mahlangu, Yesim Dargaud,Víctor Jiménez‐Yuste,Cédric Hermans

Haemophilia (2024)

引用0浏览0引用

Challenges in determining the severity of haemophilia A: An insight in discrepancies between factor VIII assays

M. -A. van Dievoet, I. Derclaye, S. Desmet, C. Gavard, C. Lambert,C. Hermans

HAEMOPHILIA (2024): 37-37

引用0浏览0引用

Change in Hemophilia Joint Health Score (HJHS) During the Phase 3 XTEND-1 Study of Efanesoctocog Alfa in Patients with Severe Hemophilia A

R. Klamroth,A. von Drygalski,C. Hermans,E. Santagostino, J. Dumont,L. Abad-Franch,A. Willemze,L. Khoo

Hämostaseologie (2024)

引用0浏览0引用

HIV Comorbid Infection and Etranacogene Dezaparvovec Therapy: Efficacy and Safety Results from Phase 2b and Pivotal Phase 3 HOPE-B Trials 3 Years after Administration

S. Pipe,E. Gomez,C. Hermans,A. Giermasz,P. Kampmann,R. Lemons,N. Galante,S. Le Quellec,P. Monahan

Hämostaseologie (2024)

引用0浏览0引用

International Data Integration Program of the WFH World Bleeding Disorders Registry: Bringing Europe Data to the Global Stage

E. Ayoub,D. Coffin, C. Lambert,B. Konkle,C. Hermans,J. O'Hara,S. Diop,G. F. Pierce,E. Gouider,A. Iorio

HAEMOPHILIA (2024): 56-57

引用0浏览0引用

Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany

Niklaus Meier,Hendrik Fuchs,Katya Galactionova,Cédric Hermans,Mark Pletscher,Matthias Schwenkglenks

PharmacoEconomics - open (2024)

引用0浏览0引用

Long-term Outcomes with Emicizumab in Hemophilia A Without Inhibitors: Results from the HAVEN 3 and 4 Studies

Johnny Mahlangu,Victor Jimenez-Yuste,Giuliana Ventriglia,Markus Niggli, Simona Barlera,Cedric Hermans,Michaela Lehle,Pratima Chowdary, Lyle Jew,Jerzy Windyga,Laurent Frenzel,Christophe Schmitt,Giancarlo Castaman,Steven W. Pipe

Research and Practice in Thrombosis and Haemostasispp.102364-102364, (2024)

引用0浏览0WOS引用

Acquired Von Willebrand Syndrome Associated with a Smoldering Multiple Myeloma, Successfully Treated by Daratumumab, Lenalidomide, and Dexamethasone

Michael Iarossi,Marie-Christiane Madeleine Vekemans, Nicolas Weynants,Cedric Hermans

ACTA HAEMATOLOGICAno. 5 (2024): 587-591

引用0浏览0WOS引用

Emicizumab as a primary and immediate standalone therapy for acquired haemophilia A: Shaping a novel therapeutic approach for a complex hematological condition

M. Thiry, C. Lambert,M. -A. Van Dievoet,C. Hermans

HAEMOPHILIA (2024): 79-80

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn